Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Suciu

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|July 27, 2016
Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic SyndromesS Suciu, W Zeller, W Fiedler, et al.
Haematology and Blood Transfusion|January 1, 1990
EORTC Leukemia Group trials on acute myeloid leukemias: an overviewM Hayat, R Zittoun, P Strychmans, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1986
Calcitonin deficiency in primary hypothyroidismJ J Body, N Demeester-Mirkine, A Borkowski, et al.
Physiologie (Bucarest)|April 1, 1978
The effect of prolonged dextran administration in guinea pigsF R Schneider, J Avram, A M Radu, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|April 12, 2024
Parastomal hernia repair according to Modified Stapled Mesh Stoma Reinforcement Technique (mSMART): which are the results ?B Romain, A Villemin, S Suciu, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 17, 2021
Nanostructure-based therapies for liver fibrosisD D Zugravu Pop, D R Mitrea, S Suciu, et al.
Melanoma Research|June 1, 1994
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)C Scheibenbogen, U Keilholz, J Mytilineos, et al.
Cancer Genetics and Cytogenetics|July 1, 1988
Trisomy 4 in two cases of acute myelomonocytic leukemiaS Suciu, H J Weh, R Kuse, et al.
The Journal of International Medical Research|September 29, 2007
Defining the prognostic value for galectin-3 in cutaneous melanomaP Vereecken, G Ghanem, R Morandini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|July 27, 2016
Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic SyndromesS Suciu, W Zeller, W Fiedler, et al.
Haematology and Blood Transfusion|January 1, 1990
EORTC Leukemia Group trials on acute myeloid leukemias: an overviewM Hayat, R Zittoun, P Strychmans, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1986
Calcitonin deficiency in primary hypothyroidismJ J Body, N Demeester-Mirkine, A Borkowski, et al.
Physiologie (Bucarest)|April 1, 1978
The effect of prolonged dextran administration in guinea pigsF R Schneider, J Avram, A M Radu, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|April 12, 2024
Parastomal hernia repair according to Modified Stapled Mesh Stoma Reinforcement Technique (mSMART): which are the results ?B Romain, A Villemin, S Suciu, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 17, 2021
Nanostructure-based therapies for liver fibrosisD D Zugravu Pop, D R Mitrea, S Suciu, et al.
Melanoma Research|June 1, 1994
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)C Scheibenbogen, U Keilholz, J Mytilineos, et al.
Cancer Genetics and Cytogenetics|July 1, 1988
Trisomy 4 in two cases of acute myelomonocytic leukemiaS Suciu, H J Weh, R Kuse, et al.
The Journal of International Medical Research|September 29, 2007
Defining the prognostic value for galectin-3 in cutaneous melanomaP Vereecken, G Ghanem, R Morandini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
Pageof 15